Acupuncture for premature ovarian insufficiency: a systemic neuroendocrine perspective
Abstract
Premature ovarian insufficiency (POI) is increasingly viewed not merely as an ovarian-centered reproductive disorder but as a systemic neuroendocrine condition characterized by multilevel dysregulation spanning the central nervous system, ovaries, immune system, metabolism, and stress-response networks. Beyond disruption of the hypothalamic-pituitary-ovarian (HPO) axis, POI involves impairment of the KNDy-GnRH network, chronic inflammatory activation, gut-ovary axis-related metabolic disturbances, and dysregulation of the hypothalamic-pituitary-adrenal (HPA) axis and autonomic nervous system. Acupuncture has been proposed as a multi-target neuroendocrine intervention whose effects may extend beyond local ovarian regulation toward broader physiological modulation. Available evidence suggests that acupuncture may influence reproductive hormone regulation, including follicle-stimulating hormone (FSH), luteinizing hormone (LH), and estradiol (E2), and may be associated with changes in ovarian reserve-related indicators and menstrual function. Some studies also report effects on stress-related endocrine activity, autonomic function, and emotional symptoms, potentially involving inflammatory and metabolic pathways. Experimental evidence further suggests possible effects on hypothalamic neuropeptide signaling, ovarian oxidative stress and inflammation, and systemic stress-metabolic pathways. However, the current evidence is limited by small sample sizes, short follow-up durations,…
Read the paper
Related studies
- Increased expression of circulating miRNA-93 in women with polycystic ovary syndrome may represent a novel, non-invasive biomarker for diagnosis
- Identification of key genes associated with polycystic ovary syndrome (PCOS) and ovarian cancer using an integrated bioinformatics analysis
- Identification of key pathways and genes in polycystic ovary syndrome via integrated bioinformatics analysis and prediction of small therapeutic molecules
- Regulation of Androgen Receptor Expression Alters AMPK Phosphorylation in the Endometrium: In Vivo and In Vitro Studies in Women with Polycystic Ovary Syndrome
- Effect of oral administration of low-dose follicle stimulating hormone on hyperandrogenized mice as a model of polycystic ovary syndrome
- Systems pharmacology to investigate the interaction of berberine and other drugs in treating polycystic ovary syndrome
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.